Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Long-term Activity Ratios (Summary)
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
The analysis of investment activity ratios between 2011 and 2016 reveals a period of volatility in asset utilization, particularly during the 2014 fiscal year, contrasted by a general increase in equity efficiency.
- Net Fixed Asset Turnover
- This ratio exhibited significant volatility over the six-year period. After reaching a peak of 117.67 in 2012, a substantial decline was observed, reaching a low of 61.93 in 2014. A partial recovery occurred in 2015, with the ratio settling at 83.79 by 2016. This pattern suggests a period of increased investment in fixed assets or a temporary decrease in revenue generation relative to those assets during the middle of the period.
- Total Asset Turnover
- A similar trend is evident in total asset turnover, which remained stable above 3.50 from 2011 to 2013. A notable contraction occurred in 2014, where the ratio dropped to 2.66, before rebounding to 3.37 by 2016. The synchronization between this metric and net fixed asset turnover indicates that the overall asset efficiency dip in 2014 was closely tied to the utilization and scaling of long-term assets.
- Equity Turnover
- Equity turnover demonstrated a general upward trajectory, increasing from 15.52 in 2011 to 21.39 in 2016. A significant peak was noted in 2015, where the ratio reached 22.38. This indicates an improved capacity to generate sales from the equity base, suggesting a more aggressive use of financial leverage or an increase in operational scale relative to shareholder investment.
In summary, while asset-based efficiency ratios experienced a significant downturn in 2014, a recovery was observed in subsequent years. Simultaneously, the steadily increasing equity turnover indicates a shift toward higher efficiency in utilizing equity to drive revenue growth.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Net Fixed Asset Turnover
| Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Revenues | 190,884) | 179,045) | 137,609) | 122,455) | 122,734) | 112,084) | |
| Property, plant and equipment, net | 2,278) | 2,045) | 2,222) | 1,321) | 1,043) | 991) | |
| Long-term Activity Ratio | |||||||
| Net fixed asset turnover1 | 83.79 | 87.55 | 61.93 | 92.70 | 117.67 | 113.10 | |
| Benchmarks | |||||||
| Net Fixed Asset Turnover, Competitors2 | |||||||
| Abbott Laboratories | — | — | — | — | — | — | |
| Elevance Health Inc. | — | — | — | — | — | — | |
| Intuitive Surgical Inc. | — | — | — | — | — | — | |
| Medtronic PLC | — | — | — | — | — | — | |
| UnitedHealth Group Inc. | — | — | — | — | — | — | |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Net fixed asset turnover = Revenues ÷ Property, plant and equipment, net
= 190,884 ÷ 2,278 = 83.79
2 Click competitor name to see calculations.
An analysis of the company's investment activity from 2011 to 2016 reveals a period of significant scale expansion and fluctuating asset efficiency. While revenues exhibited consistent growth, the efficiency of fixed asset utilization experienced notable volatility, particularly between 2013 and 2015.
- Revenue Growth Trends
- Revenues demonstrated a strong upward trajectory, increasing from 112,084 million USD in 2011 to 190,884 million USD in 2016. A particularly substantial increase occurred between 2014 and 2015, where revenues grew by approximately 30% in a single fiscal year.
- Fixed Asset Expansion
- Net property, plant, and equipment grew from 991 million USD in 2011 to 2,278 million USD in 2016. A significant capital investment phase is evident in 2014, where the net asset base increased by approximately 68% compared to the previous year, rising from 1,321 million USD to 2,222 million USD.
- Net Fixed Asset Turnover Analysis
- The net fixed asset turnover ratio peaked in 2012 at 117.67 before entering a period of decline. A sharp contraction was observed in 2014, with the ratio dropping to a period low of 61.93. This decline correlates directly with the aggressive expansion of the net fixed asset base, which outpaced revenue growth during that specific interval.
- Asset Utilization Recovery
- A partial recovery in asset efficiency occurred in 2015, with the ratio rising to 87.55. This improvement was driven by a surge in revenues coupled with a slight reduction in net property, plant, and equipment. By 2016, the ratio stabilized at 83.79, indicating that while the company maintains a larger asset base than in 2011, the current level of revenue generation per unit of fixed asset remains below the efficiency levels seen at the start of the period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Total Asset Turnover
| Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Revenues | 190,884) | 179,045) | 137,609) | 122,455) | 122,734) | 112,084) | |
| Total assets | 56,563) | 53,870) | 51,759) | 34,786) | 33,093) | 30,886) | |
| Long-term Activity Ratio | |||||||
| Total asset turnover1 | 3.37 | 3.32 | 2.66 | 3.52 | 3.71 | 3.63 | |
| Benchmarks | |||||||
| Total Asset Turnover, Competitors2 | |||||||
| Abbott Laboratories | — | — | — | — | — | — | |
| Elevance Health Inc. | — | — | — | — | — | — | |
| Intuitive Surgical Inc. | — | — | — | — | — | — | |
| Medtronic PLC | — | — | — | — | — | — | |
| UnitedHealth Group Inc. | — | — | — | — | — | — | |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Total asset turnover = Revenues ÷ Total assets
= 190,884 ÷ 56,563 = 3.37
2 Click competitor name to see calculations.
Between the fiscal years ending March 31, 2011, and March 31, 2016, a consistent expansion in both revenue and the asset base is observed. Total revenues grew from 112,084 million USD to 190,884 million USD, while total assets increased from 30,886 million USD to 56,563 million USD over the same period.
- Asset Utilization Trends
- The total asset turnover ratio exhibited a period of relative stability and peak efficiency between 2011 and 2013, moving from 3.63 to a high of 3.71 before settling at 3.52. This indicates a consistent ability to generate revenue relative to the size of the investment in assets during the early part of the period.
- Analysis of the 2014 Efficiency Decline
- A significant contraction in the total asset turnover ratio occurred in 2014, dropping to 2.66. This decline is directly attributable to a substantial increase in total assets, which rose by approximately 48% from 34,786 million USD in 2013 to 51,759 million USD in 2014. The rapid expansion of the asset base outpaced revenue growth in that fiscal year, leading to a temporary reduction in overall asset productivity.
- Recovery and Scaling Patterns
- Following the 2014 low, a recovery trend is evident, with the ratio improving to 3.32 in 2015 and 3.37 in 2016. This rebound was primarily driven by a sharp increase in revenues, most notably in 2015, where revenues jumped from 137,609 million USD to 179,045 million USD. This suggests that the assets acquired or invested in 2014 were successfully leveraged to drive higher sales volumes in subsequent years.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Equity Turnover
| Mar 31, 2016 | Mar 31, 2015 | Mar 31, 2014 | Mar 31, 2013 | Mar 31, 2012 | Mar 31, 2011 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||
| Revenues | 190,884) | 179,045) | 137,609) | 122,455) | 122,734) | 112,084) | |
| Total McKesson Corporation stockholders’ equity | 8,924) | 8,001) | 8,522) | 7,070) | 6,831) | 7,220) | |
| Long-term Activity Ratio | |||||||
| Equity turnover1 | 21.39 | 22.38 | 16.15 | 17.32 | 17.97 | 15.52 | |
| Benchmarks | |||||||
| Equity Turnover, Competitors2 | |||||||
| Abbott Laboratories | — | — | — | — | — | — | |
| Elevance Health Inc. | — | — | — | — | — | — | |
| Intuitive Surgical Inc. | — | — | — | — | — | — | |
| Medtronic PLC | — | — | — | — | — | — | |
| UnitedHealth Group Inc. | — | — | — | — | — | — | |
Based on: 10-K (reporting date: 2016-03-31), 10-K (reporting date: 2015-03-31), 10-K (reporting date: 2014-03-31), 10-K (reporting date: 2013-03-31), 10-K (reporting date: 2012-03-31), 10-K (reporting date: 2011-03-31).
1 2016 Calculation
Equity turnover = Revenues ÷ Total McKesson Corporation stockholders’ equity
= 190,884 ÷ 8,924 = 21.39
2 Click competitor name to see calculations.
The financial trajectory from 2011 to 2016 is characterized by substantial revenue expansion coupled with relatively stable stockholders' equity, resulting in a significant overall increase in equity turnover efficiency.
- Revenue Growth Trends
- Revenues demonstrated consistent growth over the six-year period, rising from US$ 112,084 million in 2011 to US$ 190,884 million in 2016. A significant acceleration is observed between 2014 and 2015, where revenues jumped from US$ 137,609 million to US$ 179,045 million, representing a substantial increase in top-line activity.
- Stockholders' Equity Stability
- Total stockholders' equity remained relatively stable, fluctuating within a narrow range between US$ 6,831 million in 2012 and US$ 8,924 million in 2016. The lack of proportional growth in equity relative to the rapid increase in revenues suggests a lean capital structure and a reliance on operational efficiency or other financing sources to fund growth.
- Equity Turnover Performance
- The equity turnover ratio exhibited a general upward trend, increasing from 15.52 in 2011 to 21.39 in 2016. A peak efficiency level of 22.38 was reached in 2015, coinciding with the period of most rapid revenue growth. While a slight decline occurred in 2016, the ratio remained significantly higher than the levels observed in the first half of the period, indicating a marked improvement in the company's ability to generate revenue from its equity base.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?